These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26301108)

  • 1. Melanonychia Secondary to Long-Term Treatment with Hydroxycarbamide: An Essential Thrombocytosis Case.
    Malkan UY; Gunes G; Eliacik E; Yayar O; Haznedaroglu IC
    Case Rep Hematol; 2015; 2015():653178. PubMed ID: 26301108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanonychia and mucocutaneous hyperpigmentation from hydroxyurea use for the treatment of essential thrombocytosis.
    Karanth SS; Gupta A; Prabhu M
    Singapore Med J; 2014 Jan; 55(1):e7-8. PubMed ID: 24452985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nail pigmentation due to hydroxycarbamide.
    Ceulen RP; Frank J; Poblete-Gutiérrez P
    Int J Dermatol; 2007 Nov; 46 Suppl 3():13-5. PubMed ID: 17973880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal melanonychia associated with hydroxyurea therapy in a patient with essential thrombocytosis.
    Cohen AD; Hallel-Halevy D; Hatskelzon L; Peretz E; Halevy S
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):137-9. PubMed ID: 10568495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dasatinib-Induced Transverse Melanonychia.
    Tyagi M; Gaurav V; Kaur J
    Skin Appendage Disord; 2023 Dec; 9(6):449-452. PubMed ID: 38058546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term management of thrombocytosis in essential thrombocythaemia.
    Birgegård G
    Ann Hematol; 2009 Jan; 88(1):1-10. PubMed ID: 18629498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Longitudinal melanonychia induced by hydroxyurea therapy].
    Neynaber S; Wolff H; Plewig G; Wienecke R
    J Dtsch Dermatol Ges; 2004 Jul; 2(7):588-91. PubMed ID: 16281621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained Regression of Hydroxycarbamide Induced Actinic Keratoses after Switching to Anagrelide.
    Gaitanis G; Gougopoulou D; Kapsali E; Bassukas ID
    Case Rep Dermatol Med; 2018; 2018():2874012. PubMed ID: 29780645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anagrelide: new drug. Essential thrombocythaemia: further evaluation needed for this last-resort treatment.
    Prescrire Int; 2006 Jun; 15(83):83-6. PubMed ID: 16764090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal melanonychia and subungual hemorrhage in a patient with systemic lupus erythematosus treated with hydroxychloroquine.
    Zhang S; Liu X; Cai L; Zhang J; Zhou C
    Lupus; 2019 Jan; 28(1):129-132. PubMed ID: 30428763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-Onset Hydroxyurea-Induced Melanonychia and Tongue Hyperpigmentation in a Patient With Polycythemia Vera: A Case Report.
    Letete N; Vaz D
    Cureus; 2024 Feb; 16(2):e53642. PubMed ID: 38449930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired melanonychia in chilean patients with essential thrombocythemia treated with hydroxyurea: a report of 7 clinical cases and review of the literature.
    Murray NP; Tapia P; Porcell J; Echavarria M; Suazo H
    ISRN Dermatol; 2013; 2013():325246. PubMed ID: 23476797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophageal and Ileal Ulcers Caused by Hydroxycarbamide: A Case Report and Literature Review.
    Inaba T; Yamamoto Y; Hirayama K; Kobayashi T; Izumi N; Sakamoto H; Hatakeyama S; Matsumura M
    Intern Med; 2024 Aug; ():. PubMed ID: 39135249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxycarbamide: a user's guide for chronic myeloproliferative disorders.
    Spivak JL; Hasselbalch H
    Expert Rev Anticancer Ther; 2011 Mar; 11(3):403-14. PubMed ID: 21417854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyurea-induced Tongue Hypermelanosis and Transverse Melanonychia.
    Neculiseanu E; Harewood J; Sidhu G
    Cureus; 2019 Dec; 11(12):e6311. PubMed ID: 31938603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide-induced melanonychia in a patient with steroid dependent nephrotic syndrome: A rare presentation.
    Mehta S; Makkar V; Soha PM; Sethi S; Kaur S
    Saudi J Kidney Dis Transpl; 2019; 30(4):978-981. PubMed ID: 31464259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 66-year-old man with hydroxycarbamide induced pneumonitis.
    Derichs C; Klooster P; Vlasveld LT
    Neth J Med; 2018 Aug; 76(6):298-301. PubMed ID: 30152396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Importance of Dermatoscopy for the Diagnosis of Melanonychia.
    Ianoși SL; Calbureanu-Popescu MX; Ianoși NG; Ungureanu Mohora I; Tutunaru CV; Neagoe CD
    Curr Health Sci J; 2019; 45(1):36-41. PubMed ID: 31297260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders.
    Birgegård G; Björkholm M; Kutti J; Lärfars G; Löfvenberg E; Markevärn B; Merup M; Palmblad J; Mauritzson N; Westin J; Samuelsson J
    Haematologica; 2004 May; 89(5):520-7. PubMed ID: 15136214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nearly complete hair re-pigmentation in an older patient treated with hydroxyurea for essential thrombocytosis.
    Salmasi S; Hassan RA; Gafarzadeh Z; Dasanu CA
    J Oncol Pharm Pract; 2024 Sep; ():10781552241285591. PubMed ID: 39311334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.